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Conclusions: For the non-accelerated RT, the new GL 
increased the risk of acute mucositis by about 20%-point at 
the end of RT. This study implies that mucosal repopulation 
is compromised by the expanded CTV1 volumes during non-
accelerated RT. During accelerated RT, the risk of grade 
2+/3+ mucositis was not related to GL, plausibly due to a 
high dose intensity eliminating mucosal repopulation. 
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Purpose/Objective: IMPT is vulnerable to uncertainties due 
to sensitivity of the location of Bragg peaks. Dose delivery 
can for instance be influenced by anatomical changes, range 
and setup uncertainty. Uncertainties can be modeled with a 
number of alternative scenarios. We introduce a novel 
method for interpretation of these scenarios using TCP and 
NTCP models. 
Materials and Methods: Thirteen patients were selected 
from an imaging protocol for photon treatment based on 
location in the oropharynx and bilateral neck treatment. Two 
IMPT plans were generated where either the original PTV or 
the CTV was used as a planning objective. The prescribed 
dose was 54 Gy in 35 fractions with a SIB of 70 Gy. For eight 
uncertainty scenarios the plans were recalculated: two for 
range over- and under-shoot of 3%, six for shifts of 3 mm 
along each translational axis. Additionally, the average of the 
shift recomputations () was calculated. TCP was calculated 
with a TD50 of 60 Gy and gamma50 of 4. Fifteen NTCP 
endpoints were evaluated with models derived from 
literature. A weighted average (W_Avg) was calculated with 
an estimated probability contribution of 7% for the nominal, 
16,5% for each range scenario and 10% for each shift 
scenario. For each endpoint we evaluated the worst case and 
the percentage of patients with a threshold violation of 5% 
decrease in TCP or increase of NTCP for at least one 
scenario. Additionally, to assess the effect of random errors, 
we evaluated the scenario and the W_Avg, averaged over all 
patients. 
Results: All plans had at least one threshold violation 
representing a risk of decreased TCP or increased NTCP in the 
presence of uncertainties. We observed less TCP decrease in 
the PTV plans compared to the CTV plans (table 1). Nominal 
NTCP values and uncertainties were generally higher in PTV 
plans. Endpoints with a high risk of increased NTCP in the 
presence of uncertainties were xerostomia and mandible 
necrosis (table 1). Of the critical neurological endpoints, 
brainstem injury exceeded 5% NTCP increase in at least one 
scenario in 3 patients. The scenario (fig 1) was close to zero 
for all endpoints with a SD for CTV plans of 0.5% for both TCP 
and NTCP, for PTV plans the SD was 0.2% for TCP and 0.7% for 
NTCP. The W_Avg was also low, except for TCP endpoints in 
CTV plans where it reached -5% (table 1, fig 1).  
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Conclusions: Interpretation of uncertainty scenarios with TCP 
and NTCP models can identify endpoints at risk in the 
presence of uncertainties. TCP uncertainty is less in PTV 
plans compared to CTV plans. In contrast, for the risk of 
NTCP increase, CTV plans are more robust. The endpoints at 
risk can be used as an input to guide robust optimization, for 
instance target coverage or the max dose in the brainstem. 
For this cohort, robust optimization is not needed for random 
shift errors. Further refinement of endpoint specific 
thresholds and TCP/NTCP models is required to optimize this 
method. 
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Purpose/Objective: To create a process of standardization 
for planning and delivery of IMRT in multiple CTCs (Cancer 
Treatment Centers) in Poland and develop a Quality 
Assurance (QA) program and allow data mining at a central 
hub. 
Materials and Methods: The Euromedic Cancer Centers 
initiated a system to systematically approach the problem of 
standardization of IMRT in multiple centers in Poland. These 
centers were geographically located in Otwock, Koszalin, 
Poznan and Walbrzych. Phase I: The group required 
standardization in the following areas: 1) contouring, 2) 
dosimetric parameters for organs at risk and target, 3) the 
development of a protocol book that would define treatment 
and contouring of all TNM stages of all cancers, 4) a library of 
evidence-based medicine for treatment of all diseases, 5) the 
development of site specific experts within the Euromedic 
system who would provide review of contouring and 
treatment plans, 6) biyearly training courses in IMRT, 7) 
standardization of physics QA, immobilization and simulation 
techniques, 8) have a similar treatment planning, EMR, and 
record and verify system at all facilities, 9) peer review of 
IMRT cases, and 10) define KPIs (Key Performance 
Indicators)and CPIs (Clinical Performance Indicators) for the 
system. Phase II: 1) a centralized hub with a relational 
database that would store all data within the Euromedic 
system and direct contours and treatment plans to the 
defined site specific expert, 2) tools within the hub that 
could be utilized for contouring, fusion, and allow access to 
references, 3) KPI and CPI measured at the central hub, 4) 
establish the hub as a training center, and 5) evaluation 
metrics for physicists and physicians to be extracted from the 
hub. 
Results: In the three year time window since the start of this 
project phase I has been completed for Gynecological, 
Gastrointestinal, Head and Neck, Lung and Genitourinary 
malignancies. Peer review sessions by site specific experts 
are being performed, protocols are being utilized with 
evidence based medicine, immobilization, dosimetric 
constraints, physics and machine QA, KPI’s and CPI’s are part 
of each of the CTCs’. 
Phase II : The IT infrastructure of the hub has been put in 
place and the relational database is being constructed. 
Formal testing of the hub will begin first quarter 2015 with 
expected completion first quarter 2016. 
Conclusions: The Euromedic group was able to build the 
framework for standardization of IMRT. Phase I has been 
completed. The implementation of the hub and spoke model 
with the integration of Bioinformatics will begin first quarter 
2016.  
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Purpose/Objective: Cancer research in the National Health 
Service (NHS) has increased by 10.5% in three years since the 
formation of the National Cancer Research (NCRN) networks 
in 2000. Additionally there is a positive cultural change 
